Kaliumklorid Ps

Potassium Chloride, the active ingredient in Kaliumklorid Ps, is a potassium supplement presented as an oral formulation for systemic use. It is employed to correct low potassium levels and to support normal cellular and cardiac function in patients with electrolyte disturbances.

GNH USA supplies Kaliumklorid Ps as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics for global healthcare providers. The company adheres to stringent manufacturing standards and provides comprehensive support for product registration and distribution across multiple regions.

Kaliumklorid Ps (potassium chloride) is used to address conditions involving potassium loss or deficiency.

- Hypokalemia: restores serum potassium to the normal range, reducing the risk of cardiac arrhythmias. - Potassium deficiency: replenishes intracellular potassium stores to support muscle and nerve function. - Electrolyte imbalance (e.g., after diuretic therapy): corrects potassium depletion to maintain overall electrolyte homeostasis.

Oral potassium chloride may cause a range of adverse reactions, most of which are related to gastrointestinal irritation or electrolyte excess.

Common Side Effects: - Nausea - Abdominal discomfort - Diarrhea - Vomiting - Taste disturbance - Flatulence

Serious or Rare Side Effects: - Hyperkalemia - Cardiac arrhythmia - Severe allergic reaction (e.g., anaphylaxis) - Acute kidney injury in susceptible patients

When prescribing Kaliumklorid Ps, clinicians should observe several safety measures to minimize risk.

- Monitor serum potassium levels: obtain baseline and periodic laboratory assessments. - Adjust dose in renal impairment: reduce or avoid use in severe kidney dysfunction. - Use caution in patients with cardiac disease: avoid rapid correction of potassium. - Avoid in existing hyperkalemia: contraindicated when serum potassium is already elevated. - Review concomitant medications that affect potassium: assess additive risk. - Store at below 25°C: keep in the original pack, protect from moisture.

Potassium chloride can interact with other agents that influence potassium balance or cardiac conduction.

Major Interactions (Avoid): - ACE inhibitors and ARBs: may cause dangerous hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone, amiloride): increase risk of excess potassium. - Trimethoprim‑containing antibiotics: potentiate hyperkalemia.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium can alter digoxin toxicity. - Beta‑blockers: may mask symptoms of hyperkalemia. - NSAIDs: can reduce renal potassium excretion, raising serum levels.